In order to continue supporting customers and partners as best as possible, at ZEISS we are doing everything we can to protect our employees’ health and safety as well as maintain production in our plants and ensure our service operations.
In January, ZEISS set up a dedicated task force. We are closely assessing the latest developments together with government agencies and healthcare authorities on an ongoing basis. Decisions are made daily regarding the most sensible measures for ZEISS to take.
Of course, we will continue to be available for our customers as best we can. Some employees in individual areas are currently working remotely but can still be reached at their usual phone numbers and email addresses.
However, should our customers experience any disruptions in service at some of our sites and sales offices, we can also be contacted on these numbers.
All over the world, the company and its employees are joining the fight against the spread and consequences of the coronavirus pandemic. Read more
16 July 2021
Carl Zeiss Meditec AG (ISIN: DE0005313704) has achieved revenue of EUR 1,198.2 million after nine months of fiscal year 2020/21 (past year: EUR 967.9 million).
13 July 2021
The ZEISS Medical Ecosystem enables multiple layers of added value by connecting devices, data and applications to optimize clinical management of patients.
8 July 2021
To mark its 175th anniversary, ZEISS has donated five million euros to the future initiative for modernizing the Deutsches Museum in Munich.